| Trial ID: | L6478 |
| Source ID: | NCT00482183
|
| Associated Drug: |
Pioglitazone
|
| Title: |
Comparison Between Pioglitazone and SES With type2 DM
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Coronary Artery Disease|Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Pioglitazone
|
| Outcome Measures: |
Primary: The primary angiographic end point is in-stent luminal late loss, as determined by quantitative angiography., Within 12minths after the procedure | Secondary: Secondary end points include the percentage of in-stent stenosis of luminal diameter, the rate of restenosis., 6 months after procedure
|
| Sponsor/Collaborators: |
Sponsor: Showa University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2|PHASE3
|
| Enrollment: |
38
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2003-07
|
| Completion Date: |
2007-06
|
| Results First Posted: |
|
| Last Update Posted: |
2007-06-05
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00482183
|
